DK2026819T3 - Forebyggelse og/eller behandling af Alzheimers sygdom - Google Patents

Forebyggelse og/eller behandling af Alzheimers sygdom

Info

Publication number
DK2026819T3
DK2026819T3 DK07732916.7T DK07732916T DK2026819T3 DK 2026819 T3 DK2026819 T3 DK 2026819T3 DK 07732916 T DK07732916 T DK 07732916T DK 2026819 T3 DK2026819 T3 DK 2026819T3
Authority
DK
Denmark
Prior art keywords
alzheimer
disease
prevention
treatment
Prior art date
Application number
DK07732916.7T
Other languages
English (en)
Inventor
Jeremy Tunrbull
Edwin Yates
Susannah Patey
Original Assignee
Univ Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liverpool filed Critical Univ Liverpool
Application granted granted Critical
Publication of DK2026819T3 publication Critical patent/DK2026819T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07732916.7T 2006-05-25 2007-05-23 Forebyggelse og/eller behandling af Alzheimers sygdom DK2026819T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0610350.1A GB0610350D0 (en) 2006-05-25 2006-05-25 prevention and/or treatment of neuodegenerative disorders
PCT/GB2007/001895 WO2007138263A1 (en) 2006-05-25 2007-05-23 Prevention and/or treatment of neurodegenerative disorders

Publications (1)

Publication Number Publication Date
DK2026819T3 true DK2026819T3 (da) 2013-03-04

Family

ID=36687688

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07732916.7T DK2026819T3 (da) 2006-05-25 2007-05-23 Forebyggelse og/eller behandling af Alzheimers sygdom

Country Status (8)

Country Link
US (1) US8673880B2 (da)
EP (2) EP2026819B1 (da)
JP (1) JP5409353B2 (da)
AU (1) AU2007266849B2 (da)
CA (1) CA2652164C (da)
DK (1) DK2026819T3 (da)
GB (1) GB0610350D0 (da)
WO (1) WO2007138263A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090127031A (ko) * 2008-06-04 2009-12-09 삼성전자주식회사 무선통신 시스템에서 단말의 유휴 모드를 지원하기 위한 방법 및 장치
US9029530B2 (en) 2009-01-02 2015-05-12 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
US8232073B2 (en) 2009-01-02 2012-07-31 Zacharon Pharmaceuticals, Inc. Quantification of non-reducing end glycan residual compounds
US8809009B2 (en) 2009-01-02 2014-08-19 Biomarin Pharmaceutical Inc. Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
US8592140B2 (en) 2009-01-02 2013-11-26 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
JP5998159B2 (ja) * 2011-03-10 2016-09-28 ヴィクトリア リンク リミテッドＶｉｃｔｏｒｉａ Ｌｉｎｋ Ｌｉｍｉｔｅｄ オリゴ糖化合物
GB201108891D0 (en) * 2011-05-26 2011-07-13 King S College London Compounds which interact with histones
JP5871500B2 (ja) * 2011-06-20 2016-03-01 公益財団法人先端医療振興財団 α−Ｋｌｏｔｈｏ／ＦＧＦ２３複合体形成阻害化合物
US20140235573A1 (en) * 2011-09-29 2014-08-21 The University Of Liverpool Prevention and/or treatment of cancer and/or cancer metastasis
GB201219696D0 (en) * 2012-11-01 2012-12-12 Univ Liverpool Agents for the prevention and/or treatment of central nervous system damamge
US9994605B2 (en) 2014-03-13 2018-06-12 Universitaet Basel Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein
CN103800348B (zh) * 2014-03-13 2015-07-01 中国科学院海洋研究所 甘露葡萄糖醛酸寡糖在制备治疗或预防帕金森病和/或老年痴呆药物和/或保健品中的应用
CA2996073A1 (en) 2015-09-16 2017-03-23 Universitat Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
EP3677587A4 (en) * 2016-08-31 2021-04-14 Oji Holdings Corporation XYLOOLIGOSACCHARIDE ACID, AND METHOD FOR MANUFACTURING THE SAME
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
CA3065747C (en) 2017-05-31 2024-10-01 Oji Holdings Corporation MOISTURIZING COMPOSITION CONTAINING PENTOSANNE POLYSULFATE
PL3683242T3 (pl) 2017-09-12 2025-03-03 Oji Holdings Corporation Polisiarczan pentozanu i sposób wytwarzania polisiarczanu pentozanu
KR102533822B1 (ko) 2017-12-20 2023-05-17 오지 홀딩스 가부시키가이샤 폴리황산펜토산 및 폴리황산펜토산을 포함하는 의약

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519416D0 (en) * 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
US5262403A (en) * 1986-03-10 1993-11-16 Board Of Regents, The University Of Texas System Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II
US5380716A (en) * 1988-12-15 1995-01-10 Glycomed, Inc. Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
JPH03130230A (ja) 1989-07-31 1991-06-04 Takeda Chem Ind Ltd 記憶障害の改善・治療剤
WO1996023003A1 (en) * 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
AU706002B2 (en) 1995-06-29 1999-06-03 Pharmacia & Upjohn Ab New anticoagulants

Also Published As

Publication number Publication date
EP2026819B1 (en) 2012-11-28
US8673880B2 (en) 2014-03-18
JP5409353B2 (ja) 2014-02-05
CA2652164A1 (en) 2007-12-06
EP2384757A1 (en) 2011-11-09
AU2007266849B2 (en) 2012-05-24
CA2652164C (en) 2015-09-01
AU2007266849A1 (en) 2007-12-06
GB0610350D0 (en) 2006-07-05
US20100062998A1 (en) 2010-03-11
WO2007138263A1 (en) 2007-12-06
EP2026819A1 (en) 2009-02-25
JP2009537622A (ja) 2009-10-29

Similar Documents

Publication Publication Date Title
DK2026819T3 (da) Forebyggelse og/eller behandling af Alzheimers sygdom
DK1765388T3 (da) Kombinationsterapi til forebyggelse eller behandling af alzheimer's sygdom, og kit dertil
DK1771201T3 (da) Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
DK3067066T3 (da) Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
EP1883709A4 (en) HUMAN MICRO-RNAS AND METHOD OF INHIBITING THEM
DK1793855T4 (da) Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
DK2200616T3 (da) Mipo-hæmmere til behandling huntingtons sygdom og multipel system atrofi
PL2878297T3 (pl) Leki do leczenia lub zapobiegania chorobom zwłóknieniowym
DK2687223T4 (da) Påvisning og behandling af demens
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
DK2276485T3 (da) Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
DK1853271T3 (da) Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
EP2019825A4 (en) HEMMER OF THE REPRODUCTION OF HUMAN IMMUNE DEFICIENCY VIRUSES
EP2220046A4 (en) INHIBITORS OF THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS
EP2220095A4 (en) INHIBITORS OF THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS
EP2220076A4 (en) INHIBITORS OF THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS
EP2220084A4 (en) INHIBITORS OF THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS
ZA200801706B (en) Methods and compositions for the prevention and treatment of kidney disease
CR9878A (es) Tratamiento y profilaxis de microangiopatias
ZA200800452B (en) Methods and compositions for the prevention and treatment of kidney disease
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
ZA200708819B (en) Methods and compositions for the prevention and treatment of kidney disease
DK1981515T3 (da) MAPC behandling af hjerneskader og -sygdomme
DE602006010304D1 (de) Endoskop und optisches Tomographiesystem